New research findings provide solid evidence that annual COVID-19 vaccine booster doses continue to be advisable for certain immunocompromised people, researchers at McGill University say.

A new study published in JCI Insight suggests that interleukin-7 (IL-7), a key immune-boosting cytokine, may help critically ill COVID-19 patients by reducing life-threatening secondary infections.

COVID-19 was designated as a pandemic and rocked Boulder County residents, schools, hospitals and businesses. Five years ...

Robert Joseph Baker, 38, whose attorney previously claimed his COVID-19 symptoms contributed to killing a stranger at a ...

Vermont has the second lowest state fatality rate in the US (146.4 per 100K; Hawaii 112.8/100K). Mississippi (463.3/100K) and ...

James Tita, MD, chief clinical officer at Toledo-based Mercy Health–St. Vincent Medical Center, is retiring after 39 years, ...

For some COVID-19 patients, recovery has never been complete, but doctors at the Shirley Ryan AbilityLab are hopeful that ...

New research findings provide solid evidence that annual COVID-19 vaccine booster doses continue to be advisable for certain immunocompromised people, researchers at McGill University say. The ...

Covid-19 vaccines are being delivered by NHS staff from today (Tuesday 1 April) with more than half a million appointments booked in the last week. Since last Tuesday (25 March), 563,154 Covid-19 ...